CVN424 75 mg, CVN424 150 mg — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08 (month) in 1mo
ESTIMATED |
READOUT
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Moto
Phase 3 · Parkinson Disease |
Cerevance | CVN424 75 mg, CVN424 150 mg |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|